The PROPATRIA trial: best practices at the time were followed

The Lancet

Volumn 375, Issue 9722, 2010, Pages 1249-1250

  Gooszen, Hein G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ACUTE PANCREATITIS; AWARENESS; CLINICAL PROTOCOL; CLINICAL RESEARCH; CONFIDENTIALITY; DATA BASE; DIET SUPPLEMENTATION; HEALTH CARE; HUMAN; LETTER; MEDICAL ETHICS; MORTALITY; PATIENT INFORMATION; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZATION; RESPONSIBILITY; SCIENTIFIC LITERATURE;

EID: 77950491046     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60494-1     Document Type: Letter

References (5)

1. The Editors of The Lancet. Expression of concern-Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 375 (2010) 875-876
2. Besselink M.G., Van Santvoort H.C., Buskens E., et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008) 651-659
3. Besselink M.G., Timmerman H.M., Buskens E., Nieuwenhuijs V.B., Akkermans L.M., and Gooszen H.G. Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial. BMC Surg 4 (2004) 12
4. Banks P.A., and Freeman M.L. Practice guidelines in acute pancreatitis. Am J Gastroenterol 101 (2006) 2379-2400
5. Drenth J.P. PROPATRIA en de overvloed aan METC's. Ned Tijdschr Geneeskd 153 (2009) B522